[Skip to Navigation]
Sign In
Views 1,530
Citations 0
Invited Commentary
January 6, 2021

Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning?

Author Affiliations
  • 1Department of Surgery, University of Florida College of Medicine, Gainesville
JAMA Surg. 2021;156(3):273. doi:10.1001/jamasurg.2020.6185

In this issue of JAMA Surgery, Newton et al1 present findings from a retrospective analysis of MarketScan Commercial Database health insurance claims data that documents that fluoroquinolone use vs comparator antibiotics is associated with an increased incidence of aortic aneurysm (AA) formation within 90 days in a large cohort of US adults. Mechanistically, this association is primarily for abdominal aortic and iliac artery aneurysms, not aortic dissections (ADs) or thoracic aortic aneurysms. The association was present across all age groups (≥35 to <65 years) and was consistent across sex and comorbidities. The study also documents that adult patients were more likely to undergo aneurysm repair (hazard ratio, 1.88; 95% CI, 1.44-2.46).

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words